Phenelzine	NNP
and/or	CC
its	PRP$
metabolites	NNS
also	RB
inhibit	VBP
at	IN
least	JJS
two	CD
other	JJ
enzymes	NNS
to	IN
a	DT
lesser	JJR
extent	NN
,	,
of	IN
which	WDT
are	VBP
alanine	JJ
transaminase	NN
(	-LRB-
ALA	NNP
-	HYPH
T	NNP
)	-RRB-
,	,
and	CC
?-Aminobutyric	JJ
acid	NN
transaminase	NN
(	-LRB-
GABA	NNP
-	HYPH
T	NNP
)	-RRB-
,	,
the	DT
latter	NN
of	IN
which	WDT
is	VBZ
not	RB
caused	VBN
by	IN
phenelzine	NN
itself	PRP
,	,
but	CC
by	IN
a	DT
phenelzine	NN
metabolite	JJ
phenylethylidenehydrazine	NN
(	-LRB-
PEH	NNP
)	-RRB-
.	.

GABA	NNP
is	VBZ
the	DT
major	JJ
inhibitory	NN
neurotransmitter	NN
in	IN
the	DT
mammalian	JJ
central	JJ
nervous	JJ
system	NN
,	,
and	CC
is	VBZ
very	RB
important	JJ
for	IN
the	DT
normal	JJ
suppression	NN
of	IN
anxiety	NN
and	CC
stress	NN
,	,
as	RB
well	RB
as	IN
keeping	VBG
depression	NN
at	IN
bay	NN
.	.

It	PRP
is	VBZ
thought	VBN
that	IN
phenelzine	NN
's	POS
action	NN
in	IN
increasing	VBG
GABA	NNP
concentrations	NNS
may	MD
significantly	RB
contribute	VB
to	IN
its	PRP$
antidepressant	NN
,	,
and	CC
especially	RB
,	,
anxiolytic/antipanic	JJ
properties	NNS
.	.

As	IN
for	IN
ALA	NNP
-	HYPH
T	NNP
inhibition	NN
,	,
though	IN
the	DT
consequences	NNS
of	IN
disabling	VBG
this	DT
enzyme	NN
are	VBP
currently	RB
not	RB
well	RB
understood	VBN
,	,
there	EX
is	VBZ
some	DT
evidence	NN
to	IN
suggest	VBP
that	IN
it	PRP
is	VBZ
this	DT
action	NN
of	IN
the	DT
hydrazines	NNS
(	-LRB-
including	VBG
phenelzine	NN
)	-RRB-
which	WDT
may	MD
be	VB
responsible	JJ
for	IN
the	DT
occasional	JJ
incidence	NN
of	IN
hepatitis	NN
and	CC
liver	NN
failure	NN
.	.

